NOL10缺失导致NUP98::DDX10白血病疾病进展受损
NUP98::DDX10融合蛋白含推定RNA解旋酶DDX10,其致白血病机制不明。本研究发现DDX10部分24个氨基酸对细胞永生化与白血病发生至关重要,NOL10与该24个氨基酸互作并为NUP98::DDX10白血病发展的关键依赖;小鼠模型中Nol10缺失损害疾病进展并改善生存;NOL10与NUP98::DDX10协同调控丝氨酸生物合成通路并稳定ATF4 mRNA。
要点
- NUP98::DDX10中DDX10部分24个氨基酸对细胞永生化与白血病发生至关重要。
- NOL10与上述24个氨基酸互作,是NUP98::DDX10白血病发展的关键依赖。
- 小鼠模型中Nol10缺失损害疾病进展并改善生存。
核心结论
- NOL10是NUP98::DDX10白血病的关键调控因子。
- 靶向NOL10或其调控的丝氨酸合成通路可能是有效治疗途径。
研究设计与样本
- 研究采用NUP98::DDX10白血病小鼠模型及细胞永生化与白血病发生相关实验。
主要发现
- NUP98::DDX10中DDX10部分24个氨基酸对细胞永生化与白血病发生至关重要。
- NOL10与上述24个氨基酸互作,是NUP98::DDX10白血病发展的关键依赖。
- 小鼠模型中Nol10缺失损害疾病进展并改善生存。
- NOL10与NUP98::DDX10协同调控丝氨酸生物合成通路并稳定ATF4 mRNA。
临床怎么用
- 作者认为靶向NOL10或其调控的丝氨酸合成通路可能是有效治疗途径。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
NUP98 rearrangements associated with acute myeloid leukemia and myelodysplastic syndromes generate NUP98-fusion proteins. One such fusion protein, NUP98::DDX10, contains the putative RNA helicase DDX10. The molecular mechanism by which NUP98::DDX10 induces leukemia is not well understood. Here, we show that 24 amino acids within the DDX10 moiety of NUP98::DDX10 are crucial for cell immortalization and leukemogenesis. NOL10, nucleolar protein 10, interacts with the 24 amino acids, and NOL10 is a critical dependency of NUP98::DDX10 leukemia development. Studies in a mouse model of NUP98::DDX10 leukemia showed that loss of Nol10 impaired disease progression and improved survival. We also identified a novel function of NOL10 in that it acts cooperatively with NUP98::DDX10 to regulate serine biosynthesis pathways and stabilize ATF4 mRNA. Collectively, these findings suggest that NOL10 is a critical regulator of NUP98::DDX10 leukemia and that targeting NOL10 (or the serine synthesis pathway regulated by NOL10) may be an effective therapeutic approach.
引用
- Shima Y, Yamagata K, Kuroki Y, et al. Loss of NOL10 leads to impaired disease progression of NUP98::DDX10 leukemia. Leukemia. 2025. PMID: 40263434. doi:10.1038/s41375-025-02607-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。